Alfresa Holdings Corporation Share Price

Equities

2784

JP3126340003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 11:30:00 14/06/2024 am IST 5-day change 1st Jan Change
2,120 JPY +0.90% Intraday chart for Alfresa Holdings Corporation -2.95% -11.54%

Financials

Sales 2024 2,858B 18.15B 1,517B Sales 2025 * 2,926B 18.58B 1,553B Capitalization 396B 2.52B 210B
Net income 2024 29.56B 188M 15.69B Net income 2025 * 27.5B 175M 14.6B EV / Sales 2024 0.15 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.14 x
P/E ratio 2024
14.4 x
P/E ratio 2025 *
14.3 x
Employees 11,772
Yield 2024
3.15%
Yield 2025 *
3.25%
Free-Float 84.72%
More Fundamentals * Assessed data
Dynamic Chart
Healios Enters Alliance, Bond Purchase Deal with Alfresa MT
Alfresa Holdings' Subsidiary Forms Pact with National Center for Child Health and Development to Supply Somatic Stem Cell Materials MT
Alfresa's Fiscal 2023 Attributable Profit Rises 15% on Net Sales Growth MT
Alfresa Holdings Corporation Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2023 and Fiscal Year March 31, 2024 CI
Alfresa Holdings Completes 35 Billion Yen Share Buyback program MT
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2023, has closed with 15,201,200 shares, representing 7.65% for ¥34,999.80 million. CI
Alfresa unit Cell Resources Partners with Miltenyi Biotec to Advance Cell Culture Automation in Gene Cell Therapy Market MT
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
More news
1 day+0.90%
1 week-2.95%
Current month-4.22%
1 month-10.44%
3 months-4.57%
6 months-12.81%
Current year-11.54%
More quotes
1 week
2 082.50
Extreme 2082.5
2 213.50
1 month
2 082.50
Extreme 2082.5
2 279.00
Current year
2 082.50
Extreme 2082.5
2 554.50
1 year
2 082.50
Extreme 2082.5
2 643.50
3 years
1 505.00
Extreme 1505
2 643.50
5 years
1 505.00
Extreme 1505
2 807.00
10 years
1 281.00
Extreme 1281
3 350.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 64 01/18/01
President 61 01/07/01
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 48 01/20/01
President 61 01/07/01
Director/Board Member 70 01/20/01
More insiders
Date Price Change Volume
14/24/14 2,120 +0.90% 672,600
13/24/13 2,101 -1.66% 270,600
12/24/12 2,136 -1.41% 416,200
11/24/11 2,167 -1.10% 256,700
10/24/10 2,191 -0.30% 242,400

Delayed Quote Japan Exchange, June 14, 2024 at 11:30 am IST

More quotes
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,120 JPY
Average target price
2,240 JPY
Spread / Average Target
+5.66%
Consensus